Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Outcomes of Children and Adolescents with Acute Myeloid Leukemia Given a Low-Versus Standard-Dose Chemotherapy Regimen for Remission Induction (CALSIII-AML18): A Multicenter, Phase 3, Randomized, Noninferiority Trial

Blood (2023) 142 (Supplement 1): 729.

https://doi.org/10.1182/blood-2023-189253

Published: 2023

Journal Articles

A Multicenter Clinical Study with Reduced Intensive Chemotherapy for Induction Remission of Pediatric Acute Megakaryoblastic Leukemia

Blood (2023) 142 (Supplement 1): 4276.

https://doi.org/10.1182/blood-2023-190821

Published: 2023

Journal Articles

Heritable SETBP1 Mutations Associated with Myelodysplastic Syndrome and Acute Myeloid Leukemia

Jingyi Yang, Shanlan Mo, Xudong Wei, Xiaodong Lv, Ya Zhang, Yuewen Fu, Baijun Fang, Yanli Zhang, Jian Zhou, Hu Zhou, Quande Lin, Delong Liu, Yongping Song, Qianfei Wang, Keshu Zhou

Blood (2023) 142 (Supplement 1): 5684.

https://doi.org/10.1182/blood-2023-182788

Published: 2023

Journal Articles

The Diversity of FLT3-ITD and the Prognostic Impact in Adult Acute Myeloid Leukemia

Jingyi Yang, Shanlan Mo, Xudong Wei, Xiaodong Lv, Baijun Fang, Yanli Zhang, Jian Zhou, Hu Zhou, Yuewen Fu, Quande Lin, Delong Liu, Yongping Song, Qianfei Wang, Keshu Zhou

Blood (2023) 142 (Supplement 1): 5756.

https://doi.org/10.1182/blood-2023-178989

Published: 2023

Journal Articles

Outcome and Genomic Characteristics of Non-Down Syndrome Acute Megakaryoblastic Leukemia in Children Treated with Low-Dose Chemotherapy for Induction Remission

Yixin Hu, MD, Li Gao, MD, Aili Chen, MD, Jun Lu, MD, Jie Li, MD, Hailong He, MD, Yi Wang, MD PhD, Peifang Xiao, MD, Qianfei Wang, PhD, Raul Ribeiro, MD, Shaoyan Hu, MD PhD

Blood (2019) 134 (Supplement_1): 2613.

https://doi.org/10.1182/blood-2019-129572

Published: 2019

Journal Articles

Comparable Leukemic Cells Reduction but Improved Normal Hematopoietic Regeneration with G-CSF Priming Plus Low Dose Chemotherapy Regimen Relative to Standard Chemotherapy in AML Mice Model

Ya Zhang, MS, Xiaomin Feng, MD PhD, Aili Chen, PhD, Shaoyan Hu, MD PhD, Qianfei Wang, PhD, Gang Huang, PhD

Blood (2019) 134 (Supplement_1): 1362.

https://doi.org/10.1182/blood-2019-129465

Published: 2019

Journal Articles

Cooperative Epigenetic Regulation By ASXL1 and NF1 Loss on Leukemogenesis

Peng Zhang, PhD, Fuhong He, PhD, Jie Bai, MD, Shi Chen, Stephen D. Nimer, MD, Yuan Zhou, PhD, Mingjiang Xu, MD PhD, Qianfei Wang, PhD, Feng-Chun Yang, MD PhD

Blood (2018) 132 (Supplement 1): 652.

https://doi.org/10.1182/blood-2018-99-110964

Published: 2018

Journal Articles

Myc Regulates the Development and Anti-Tumor Immunity of Natural Killer Cells

Yuting Tang, MD PhD, Xiaomei Yan, MD PhD, Di Zhan, PhD, Lijun Wen, MS, Rui Huang, MD PhD, Yue Zhang, MD PhD, Yoshihiro Hayashi, MD PhD, Qianfei Wang, PhD, Jianfeng Zhou, MD PhD, Gang Huang, PhD

Blood (2018) 132 (Supplement 1): 1113.

https://doi.org/10.1182/blood-2018-99-114180

Published: 2018

Journal Articles

Identification of APP As a Novel Candidate Familial Eosinophilia Predisposition Gene

Dan Liu, Peiling Zhang, MD, Fuhong He, PhD, Yueying Li, MD, Wenbing Liu, Xin Liu, PhD, Qianfei Wang, PhD, Jianfeng Zhou, PhD

Blood (2018) 132 (Supplement 1): 3681.

https://doi.org/10.1182/blood-2018-99-117495

Published: 2018

Journal Articles

PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia

Yingchi Zhang, Yufeng Gao, Hui Zhang, Jingliao Zhang, Fuhong He, Aleš Hnízda, Maoxiang Qian, Xiaoming Liu, Yoshihiro Gocho, Ching-Hon Pui, Tao Cheng, Qianfei Wang, Jun J. Yang, Xiaofan Zhu, Xin Liu

Blood (2018) 131 (20): 2256–2261.

https://doi.org/10.1182/blood-2017-11-817510

Published: 2018

Includes: Supplemental data

Journal Articles

HIF1A Is a Critical Downstream Mediator for Hemophagocytic Lymphohistiocytosis

Blood (2017) 130 (Supplement 1): 3565.

https://doi.org/10.1182/blood.V130.Suppl_1.3565.3565

Published: 2017

Journal Articles

Clinical Outcomes and Mutation Clearance in Children with Acute Myeloid Leukemia Treated with Low-Dose Chemotherapy Plus G-CSF for Remission Induction

Blood (2017) 130 (Supplement 1): 1397.

https://doi.org/10.1182/blood.V130.Suppl_1.1397.1397

Published: 2017

Journal Articles

Mutation Profiling Reveals Novel Epigenetics and Splicing Mutations in Chemorefractory Pediatric AML

Yingchi Zhang, PhD, Di Zhan, Peifang Xiao, MD, MIN Ruan, Jingliao Zhang, Gang Huang, PhD, Shaoyan Hu, MD PhD, Qianfei Wang, PhD, Xiaofan Zhu, MD

Blood (2017) 130 (Supplement 1): 3817.

https://doi.org/10.1182/blood.V130.Suppl_1.3817.3817

Published: 2017

Journal Articles

Global Crosstalk between Two Histone Modifications That Control Transcriptional Elongation in MLL Leukemia

Jiachen Bu, Aili Chen, PhD, Xiaomei Yan, Fuhong He, PhD, Yunzhu Dong, Yile Zhou, Jianlin He, Yoshihiro Hayashi, Di Zhan, Yanling Sun, Yue Zhang, Zhijian Xiao, Lee Grimes, Qianfei Wang, PhD, Gang Huang, PhD

Blood (2017) 130 (Supplement 1): 2495.

https://doi.org/10.1182/blood.V130.Suppl_1.2495.2495

Published: 2017

Journal Articles

Clinical Subtypes, Molecular Features and Treatment Strategies of Aggressive NK-Cell Leukemia: A Multicenter Analysis of 113 Patients

Liang Huang, MDPhD, Yuting Tang, MD, Di Wang, MD PhD, Hui Luo, MD, Min Xiao, MD PhD, Dan Liu, Na Wang, MD PhD, Jianfeng Zhou, MD PhD, Qianfei Wang, PhD

Blood (2017) 130 (Supplement 1): 2796.

https://doi.org/10.1182/blood.V130.Suppl_1.2796.2796

Published: 2017

Journal Articles

Human NOTCH4 Is a Key Target of RUNX1 in Megakaryocytic Differentiation

Yueying Li, MD, Chen Jin, Hao Bai, Shu Sun, Paul P. Liu, MD PhD, Linzhao Cheng, PhD, Qianfei Wang, PhD

Blood (2016) 128 (22): 425.

https://doi.org/10.1182/blood.V128.22.425.425

Published: 2016

Journal Articles

Downregulation of SETD2-H3K36me3 Tumor Suppression Axis Promotes MLL Leukemia through Activation of DOT1L-H3K79me2 Axis

Jiachen Bu, Aili Chen, PhD, Yunzhu Dong, PhD, Fuhong He, PhD, Xiaomei Yan, MD PhD, Yile Zhou, Di Zhan, Yoshihiro Hayashi, MD PhD, Qianfei Wang, PhD, Gang Huang, PhD

Blood (2016) 128 (22): 435.

https://doi.org/10.1182/blood.V128.22.435.435

Published: 2016

Journal Articles

Clinical Outcome and Non-Synonymous Mutation Clearance in Chinese Children with Acute Myeloid Leukemia Treated with a Low-Intensity Induction Chemotherapy Regimen

Aili Chen, PhD, Yixin Hu, MD, Xin Liu, MD PhD, Jun Lu, MD, Peifang Xiao, MD, Xinchang Zheng, Jin Yang, Ya Zhang, Jingyi Yang, MD, Fuhong He, PhD, Pinpin Sui, Hailong He, MD, Yi Wang, MD PhD, Cheng Cheng, PhD, Raul C. Ribeiro, MD, Shaoyan Hu, MD PhD, Qianfei Wang, PhD

Blood (2016) 128 (22): 2848.

https://doi.org/10.1182/blood.V128.22.2848.2848

Published: 2016

Journal Articles

SETD2, a H3K36 Lysine Methyltransferase, Is Essential for Adult Normal Hematopoiesis and Leukemia Stem Cells

Yile Zhou, Yunzhu Dong, Jiachen Bu, Xiaomei Yan, MD PhD, Yoshihiro Hayashi, MD PhD, Qianfei Wang, PhD, Jie Jin, MD PhD, Gang Huang, PhD

Blood (2016) 128 (22): 1055.

https://doi.org/10.1182/blood.V128.22.1055.1055

Published: 2016

Journal Articles

ANP32A Regulates Histone 3 Acetylation and Promotes Leukemogenesis in AML

Xuejing Yang, Xueqin Sun, PhD, Bin Lu, PhD, Qianfei Wang, PhD, Zan Huang, PhD

Blood (2016) 128 (22): 3917.

https://doi.org/10.1182/blood.V128.22.3917.3917

Published: 2016

NARROW

Outcomes of Children and Adolescents with Acute Myeloid Leukemia Given a Low-Versus Standard-Dose Chemotherapy Regimen for Remission Induction (CALSIII-AML18): A Multicenter, Phase 3, Randomized, Noninferiority Trial

A Multicenter Clinical Study with Reduced Intensive Chemotherapy for Induction Remission of Pediatric Acute Megakaryoblastic Leukemia

Heritable SETBP1 Mutations Associated with Myelodysplastic Syndrome and Acute Myeloid Leukemia

The Diversity of FLT3-ITD and the Prognostic Impact in Adult Acute Myeloid Leukemia

Outcome and Genomic Characteristics of Non-Down Syndrome Acute Megakaryoblastic Leukemia in Children Treated with Low-Dose Chemotherapy for Induction Remission

Comparable Leukemic Cells Reduction but Improved Normal Hematopoietic Regeneration with G-CSF Priming Plus Low Dose Chemotherapy Regimen Relative to Standard Chemotherapy in AML Mice Model

Cooperative Epigenetic Regulation By ASXL1 and NF1 Loss on Leukemogenesis

Myc Regulates the Development and Anti-Tumor Immunity of Natural Killer Cells

Identification of APP As a Novel Candidate Familial Eosinophilia Predisposition Gene

PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia

HIF1A Is a Critical Downstream Mediator for Hemophagocytic Lymphohistiocytosis

Clinical Outcomes and Mutation Clearance in Children with Acute Myeloid Leukemia Treated with Low-Dose Chemotherapy Plus G-CSF for Remission Induction

Mutation Profiling Reveals Novel Epigenetics and Splicing Mutations in Chemorefractory Pediatric AML

Global Crosstalk between Two Histone Modifications That Control Transcriptional Elongation in MLL Leukemia

Clinical Subtypes, Molecular Features and Treatment Strategies of Aggressive NK-Cell Leukemia: A Multicenter Analysis of 113 Patients

Human NOTCH4 Is a Key Target of RUNX1 in Megakaryocytic Differentiation

Downregulation of SETD2-H3K36me3 Tumor Suppression Axis Promotes MLL Leukemia through Activation of DOT1L-H3K79me2 Axis

Clinical Outcome and Non-Synonymous Mutation Clearance in Chinese Children with Acute Myeloid Leukemia Treated with a Low-Intensity Induction Chemotherapy Regimen

SETD2, a H3K36 Lysine Methyltransferase, Is Essential for Adult Normal Hematopoiesis and Leukemia Stem Cells

ANP32A Regulates Histone 3 Acetylation and Promotes Leukemogenesis in AML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only